Cacciapaglia, F.; Venerito, V.; Stano, S.; Fornaro, M.; Lopalco, G.; Iannone, F.
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. J. Pers. Med. 2022, 12, 353.
https://doi.org/10.3390/jpm12030353
AMA Style
Cacciapaglia F, Venerito V, Stano S, Fornaro M, Lopalco G, Iannone F.
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. Journal of Personalized Medicine. 2022; 12(3):353.
https://doi.org/10.3390/jpm12030353
Chicago/Turabian Style
Cacciapaglia, Fabio, Vincenzo Venerito, Stefano Stano, Marco Fornaro, Giuseppe Lopalco, and Florenzo Iannone.
2022. "Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis" Journal of Personalized Medicine 12, no. 3: 353.
https://doi.org/10.3390/jpm12030353
APA Style
Cacciapaglia, F., Venerito, V., Stano, S., Fornaro, M., Lopalco, G., & Iannone, F.
(2022). Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis. Journal of Personalized Medicine, 12(3), 353.
https://doi.org/10.3390/jpm12030353